tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CTNM Stock Latest News

Contineum price target raised to $20 from $14 at Baird
The FlyContineum price target raised to $20 from $14 at Baird
15d ago
CTNM
Contineum Therapeutics Expands ATM Facility, Highlights Pipeline Progress
PremiumCompany Announcements
Contineum Therapeutics Expands ATM Facility, Highlights Pipeline Progress
15d ago
8K
CTNM
Contineum reports Q4 EPS (49c), consensus (39c)
PremiumThe Fly
Contineum reports Q4 EPS (49c), consensus (39c)
15d ago
CTNM
Is CTNM a Buy, Before Earnings?
PremiumPre-Earnings
Is CTNM a Buy, Before Earnings?
18d ago
CTNM
Contineum Therapeutics Adopts 2026 Employment Inducement Equity Plan
PremiumCompany Announcements
Contineum Therapeutics Adopts 2026 Employment Inducement Equity Plan
2M ago
8K
CTNM
Contineum downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe FlyContineum downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
CTNM
Contineum 7.4M share Spot Secondary priced at $12.25
Premium
The Fly
Contineum 7.4M share Spot Secondary priced at $12.25
3M ago
CTNM
Contineum Therapeutics Submits Phase 2 Trial for PIPE-791
Premium
Company Announcements
Contineum Therapeutics Submits Phase 2 Trial for PIPE-791
3M ago
8K
CTNM
Contineum offers to sell $75M in common stock
PremiumThe Fly
Contineum offers to sell $75M in common stock
3M ago
CTNM
Contineum price target lowered to $14 from $16 at Baird
PremiumThe Fly
Contineum price target lowered to $14 from $16 at Baird
4M ago
CTNM
Contineum price target lowered to $22 from $25 at RBC Capital
PremiumThe Fly
Contineum price target lowered to $22 from $25 at RBC Capital
4M ago
CTNM
Contineum Therapeutics: Undervalued Potential in IPF with PIPE-791 Amidst PIPE-307 Setback
PremiumRatings
Contineum Therapeutics: Undervalued Potential in IPF with PIPE-791 Amidst PIPE-307 Setback
4M ago
CTNM
Positive Outlook on Contineum Therapeutics Despite Setbacks, Driven by PIPE-791’s Potential in IPF
PremiumRatingsPositive Outlook on Contineum Therapeutics Despite Setbacks, Driven by PIPE-791’s Potential in IPF
4M ago
CTNM
Closing Bell Movers: Elastic down 12% despite beat and raise
Premium
The Fly
Closing Bell Movers: Elastic down 12% despite beat and raise
4M ago
MU
GAP
Optimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments
Premium
Ratings
Optimistic Buy Rating for Contineum Therapeutics Amid Promising PIPE-791 Developments
4M ago
CTNM
Contineum Therapeutics Reports Phase 2 Trial Results
PremiumCompany Announcements
Contineum Therapeutics Reports Phase 2 Trial Results
4M ago
8K
CTNM
Contineum Therapeutics Inc trading resumes
PremiumThe Fly
Contineum Therapeutics Inc trading resumes
4M ago
CTNM
Contineum Phase 2 VISTA trial did not meet primary, secondary endpoints
PremiumThe Fly
Contineum Phase 2 VISTA trial did not meet primary, secondary endpoints
4M ago
CTNM
Contineum Therapeutics Inc trading halted, news pending
PremiumThe Fly
Contineum Therapeutics Inc trading halted, news pending
4M ago
CTNM
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities
PremiumRatingsBuy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities
5M ago
CTNM
Contineum Therapeutics Reports Increased R&D Investment Amid Losses
Premium
Company Announcements
Contineum Therapeutics Reports Increased R&D Investment Amid Losses
5M ago
CTNM
Contineum reports Q3 EPS (45c), consensus (46c)
Premium
The Fly
Contineum reports Q3 EPS (45c), consensus (46c)
5M ago
CTNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >